Healthcare
Showing 1–12 of 44 results
- May 5, 2024
Novartis has made significant progress in its pipeline development and regulatory milestones, demonstrating its commitment to innovation and pipeline progression.
- April 30, 2024
Twist Bioscience’s synthetic genes are a crucial part of its revenue stream, accounting for approximately 30% of total revenue.
- April 24, 2024
UnitedHealth Group’s commitment to diversification and innovation is evident in its organizational structure, investment in a diverse healthcare workforce, sustainability initiatives, and financial performance.
- April 24, 2024
Agilent Technologies has introduced the ProteoAnalyzer system, an innovative automated parallel capillary electrophoresis solution for protein analysis, which strengthens the company’s competitive positioning in the analytical instruments space.
- April 23, 2024
The BD Alaris Infusion System is a medical device used for the delivery of intravenous fluids and medications to patients in critical care settings.
- April 19, 2024
Takeda Pharmaceutical’s increasing research and development (R&D) expenses potentially impacting its profitability and the importance of a robust product pipeline is supported by the provided sources.
- April 19, 2024
The company has entered an exclusive development and commercialization deal with Coya Therapeutics for their investigational combination biologics for the treatment of neurodegenerative disease, ALS.
- April 18, 2024
The company’s diversified segment, which includes the neurology, dermatology, and generics businesses, is subject to competitive and pricing pressures in diversified segments.
- April 18, 2024
BioNTech reported a significant decline in its fourth-quarter profit and sales, which fell short of analysts’ expectations due to falling demand for COVID-19 vaccines. This decline was attributed to inventory write-downs by BioNTech’s collaboration partner, Pfizer.
- April 15, 2024
Veeva Systems, a leading provider of cloud-based solutions for the global life sciences industry has successfully rolled out the Veeva Compass Suite, a comprehensive suite of commercial data products designed to modernize the industry’s data infrastructure.
- April 12, 2024
The challenges faced by MDT in RAS market include integrating AI and automation in surgery, which raises many ethical challenges that warrant careful consideration.
- April 11, 2024
Merck’s oncology business, spearheaded by its flagship product KEYTRUDA, showcases the company’s proficiency in developing and marketing innovative and commercially successful therapies.